首页> 外国专利> Pirazolopiridina derived Compounds, inhibitors of FGF receptors; a process for preparing Pharmaceutical composition; Combination; Pharmaceutical; and its use to treat and prevent cancer, particularly vascularized as carcinomas of the Lung, Breast, Prostate, pancreatic, among others.

Pirazolopiridina derived Compounds, inhibitors of FGF receptors; a process for preparing Pharmaceutical composition; Combination; Pharmaceutical; and its use to treat and prevent cancer, particularly vascularized as carcinomas of the Lung, Breast, Prostate, pancreatic, among others.

机译:Pirazolopiridina衍生的化合物,FGF受体的抑制剂;制备药物组合物的方法;组合;制药;及其用于治疗和预防癌症的用途,尤其是血管化的肺癌,乳腺癌,前列腺癌,胰腺癌等。

摘要

The invention relates to FGF-inhibiting pyrazolopyrimidine derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
机译:本发明涉及通式(I)的抑制FGF的吡唑并嘧啶衍生物,涉及其制备方法及其治疗用途。

著录项

  • 公开/公告号CL2014001539A1

    专利类型

  • 公开/公告日2014-10-17

    原文格式PDF

  • 申请/专利权人 SANOFI;

    申请/专利号CL20140001539

  • 申请日2014-06-11

  • 分类号C07D471/04;A61K31/437;A61P35;A61P35/04;

  • 国家 CL

  • 入库时间 2022-08-21 15:58:27

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号